Purchase Order 75N91018P00561

<p>The National Cancer Institute awarded a purchase order to MR Solutions Americas, LLC for $1,145,600.00 on September 12, 2018, under a Total Small Business set-aside for a brand name or equal MR Solutions microPET/1203CT scanner system. Performance is at Bethesda, Maryland. The order carries a firm fixed price and completion date of February 28, 2019. The solicitation was posted August 9, 2018, with a due date of August 17, 2018.</p>

<p>The National Cancer Institute issued a purchase order to MR Solutions Americas, LLC valued at $12,150 on September 11, 2018. Place of performance is Bethesda, Maryland. The order is a firm fixed-price commercial item acquisition with no set-aside applied. Ultimate completion is scheduled for October 11, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to MR Solutions Inc. for $24,999.00 on September 14, 2017, with ultimate completion on September 13, 2018. Work is performed in San Diego, California. The order covers service of MRI systems under firm fixed price terms.</p>

The National Cancer Institute (NCI) awarded a purchase order to MR Solutions Inc. for preventive maintenance services on an MRS*PET/CT imaging scanner system, with a ceiling value of $244,510.05 and an award date of April 1, 2025. The originating solicitation designated this as a total small business set-aside under NAICS 811210, though the award is a direct procurement from the original equipment manufacturer. Work is performed at the NIH facility in Bethesda, Maryland. The order covers...

This is a $77,824 firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to MR Solutions Americas, LLC for preventative maintenance services on a government-owned MR Solutions microPET/CT imaging scanner located at the NIH campus in Bethesda, Maryland. The contract has a base period of 12 months and two 12-month option periods, for a potential total duration of approximately 3 years. This is an unrestricted commercial item...

<p>The National Cancer Institute awarded a purchase order to Bruker Biospin Corp for $697,395 on September 18, 2017, to acquire a 3T MRI system for dynamic metabolic imaging using dynamic nuclear polarization. Performance takes place in Billerica, Massachusetts. The order carries a firm fixed price and has an ultimate completion date of March 17, 2018. No set-aside was used.</p>

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $73,815 firm fixed-price purchase order to MR Solutions Inc. for preventative maintenance services on a micro positron emission tomography/computed tomography (PET/CT) imaging scanner. The contract, awarded on April 1, 2026, will be performed at the agency's Bethesda, Maryland location and is scheduled for completion by March 31, 2027. No set-aside designation was applied to this award. MR Solutions Inc., a...

<p>The National Cancer Institute awarded a $38,300 purchase order to Mediso USA LLC on September 17, 2018, for high-energy collimators for NanoSpect/CT imaging equipment. Work is performed in Boston, Massachusetts, under firm fixed-price terms, with an ultimate completion date of September 16, 2019. The order originated from a pre-solicitation opportunity posted September 12, 2018, with award decision made within five days of the stated due date.</p>

The Department of Veterans Affairs, through Veterans Integrated Service Network 15, awarded a $2.89 million firm fixed-price purchase order to MR Solutions Inc. on September 28, 2022, for a large bore 9.4 Tesla PET/MRI system. The contract, which extends through December 31, 2026, represents the delivery of advanced medical imaging equipment to support traumatic brain injury research initiatives. MR Solutions Inc., a Massachusetts-based manufacturer specializing in magnetic resonance imaging and...

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>